Skip to main content

29-04-2017 | PARP inhibitors | Article

Smoking History Predicts Sensitivity to PARP Inhibitor Veliparib in Patients with Advanced Non–Small Cell Lung Cancer

Please follow the link below to view this article in full on a third party website. Note that a subscription or payment may be required.

Related topics